Gilead Sciences, Inc. has entered into a €63M agreement with European Commission for Remdesivir. The finance of Emergency Support Instrument of the European...
Gilead Sciences, Inc. disclosed today it has acquired 49.9% equity interest in Tizona Therapeutics, Inc. for $300 million. Tizona Therapeutics, Inc. is a...
ICON Public Limited Company has disclosed that it has won multiple categories in the annual CRO Leadership Awards. This is another greatest achievement...
Shares of Mer Telemanagement Solutions Ltd skyrocketed during the trading session of Friday. The strong performance of the firm has indicated the positive...